-
Signature
-
/s/ Sarah Dale, Attorney-in-Fact for Srinivas Tallapragada
-
Issuer symbol
-
CRM
-
Transactions as of
-
22 Dec 2024
-
Net transactions value
-
-$21,621,366
-
Form type
-
4
-
Filing time
-
23 Dec 2024, 20:13:03 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRM |
Common Stock |
Options Exercise |
$0 |
+871 |
+3.5% |
$0.000000 |
25,734 |
22 Dec 2024 |
Direct |
|
| transaction |
CRM |
Common Stock |
Options Exercise |
$0 |
+1,002 |
+3.9% |
$0.000000 |
26,736 |
22 Dec 2024 |
Direct |
|
| transaction |
CRM |
Common Stock |
Sale |
$148,822 |
-438 |
-1.6% |
$339.78 |
26,298 |
23 Dec 2024 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Sale |
$171,247 |
-504 |
-1.9% |
$339.78 |
25,794 |
23 Dec 2024 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Options Exercise |
$21,283,110 |
+98,913 |
+383% |
$215.17 |
124,707 |
23 Dec 2024 |
Direct |
F2 |
| transaction |
CRM |
Common Stock |
Options Exercise |
$16,194,892 |
+74,217 |
+60% |
$218.21 |
198,924 |
23 Dec 2024 |
Direct |
F2 |
| transaction |
CRM |
Common Stock |
Sale |
$10,179,881 |
-30,140 |
-15% |
$337.75 |
168,784 |
23 Dec 2024 |
Direct |
F2, F3 |
| transaction |
CRM |
Common Stock |
Sale |
$11,968,360 |
-35,356 |
-21% |
$338.51 |
133,428 |
23 Dec 2024 |
Direct |
F2, F4 |
| transaction |
CRM |
Common Stock |
Sale |
$15,501,960 |
-45,653 |
-34% |
$339.56 |
87,775 |
23 Dec 2024 |
Direct |
F2, F5 |
| transaction |
CRM |
Common Stock |
Sale |
$15,734,680 |
-46,197 |
-53% |
$340.60 |
41,578 |
23 Dec 2024 |
Direct |
F2, F6 |
| transaction |
CRM |
Common Stock |
Sale |
$3,354,951 |
-9,825 |
-24% |
$341.47 |
31,753 |
23 Dec 2024 |
Direct |
F2, F7 |
| transaction |
CRM |
Common Stock |
Sale |
$2,039,468 |
-5,959 |
-19% |
$342.25 |
25,794 |
23 Dec 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRM |
Restricted Stock Units |
Options Exercise |
$0 |
-871 |
-50% |
$0.000000 |
872 |
22 Dec 2024 |
Common Stock |
871 |
$0.000000 |
Direct |
F8, F9 |
| transaction |
CRM |
Restricted Stock Units |
Options Exercise |
$0 |
-1,002 |
-17% |
$0.000000 |
5,013 |
22 Dec 2024 |
Common Stock |
1,002 |
$0.000000 |
Direct |
F8, F10 |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-98,913 |
-94% |
$0.000000 |
6,595 |
23 Dec 2024 |
Common Stock |
98,913 |
$215.17 |
Direct |
F2, F11 |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-74,217 |
-69% |
$0.000000 |
33,735 |
23 Dec 2024 |
Common Stock |
74,217 |
$218.21 |
Direct |
F2, F12 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: